Extendicare Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Extendicare hat ein Gesamteigenkapital von CA$90.3M und eine Gesamtverschuldung von CA$280.4M, wodurch sich der Verschuldungsgrad auf 310.7% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen CA$701.0M bzw. CA$610.7M. Extendicare Das EBIT des Unternehmens beträgt CA$78.8M, so dass der Zinsdeckungsgrad 5.5 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von CA$90.5M.

Wichtige Informationen

310.7%

Verhältnis von Schulden zu Eigenkapital

CA$280.41m

Verschuldung

Zinsdeckungsgrad	5.5x
Bargeld	CA$90.55m
Eigenkapital	CA$90.26m
Gesamtverbindlichkeiten	CA$610.75m
Gesamtvermögen	CA$701.01m

Jüngste Berichte zur Finanzlage

Is Extendicare (TSE:EXE) Using Too Much Debt?

May 11

Recent updates

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Jun 20

Extendicare (TSE:EXE) Is Paying Out A Dividend Of CA$0.04

May 24

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Mar 16

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: EXEDie kurzfristigen Aktiva des Unternehmens (CA$212.8M) decken seine kurzfristigen Passiva (CA$259.4M) nicht.

Langfristige Verbindlichkeiten: EXEDie kurzfristigen Vermögenswerte des Unternehmens (CA$212.8M) decken seine langfristigen Verbindlichkeiten (CA$351.3M) nicht.

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: EXEDie Nettoverschuldung im Verhältnis zum Eigenkapital (210.3%) wird als hoch angesehen.

Schulden abbauen: EXE Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 382.3% auf 310.7% zurückgegangen.

Schuldendeckung: EXEDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (33.1%).

Zinsdeckung: EXEDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (5.5x Coverage) gut gedeckt.

Extendicare Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Is Extendicare (TSE:EXE) Using Too Much Debt?

Recent updates

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of June 2024, Payable on July 15, 2024

Extendicare (TSE:EXE) Is Paying Out A Dividend Of CA$0.04

Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A Director

Dividend of CA$0.04 announced

First quarter 2024 earnings released: EPS: CA$0.16 (vs CA$0.14 in 1Q 2023)

Extendicare Inc. Declares Cash Dividend for the Month of May 2024, Payable on June 17, 2024

Upcoming dividend of CA$0.04 per share

Extendicare Inc., Annual General Meeting, May 23, 2024

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of April 2024, Payable on May 15, 2024

Extendicare Inc. to Report Q1, 2024 Results on May 15, 2024

CEO, President & Director exercised options to buy CA$450k worth of stock.

Upcoming dividend of CA$0.04 per share

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Price target increased by 10% to CA$8.00

Dividend of CA$0.04 announced

Full year 2023 earnings released: EPS: CA$0.40 (vs CA$0.051 loss in FY 2022)

Extendicare Inc. Declares Cash Dividend for the Month of March 2024, Payable on April 15, 2024

Upcoming dividend of CA$0.04 per share

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of February 2024, Payable on March 15, 2024

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare Inc. to Report Q4, 2023 Results on Mar 07, 2024

Extendicare Inc. Declares Cash Dividend for the Month of December 2023, Payable on January 15, 2024

Independent Director recently bought CA$99k worth of stock

Upcoming dividend of CA$0.04 per share at 7.4% yield

Extendicare Inc. Declares Cash Dividend for the Month of November 2023, Payable on December 15, 2023

Third quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.049 loss in 3Q 2022)

Upcoming dividend of CA$0.04 per share at 7.9% yield

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of October 2023, Payable on November 15, 2023

Extendicare Inc. to Report Q3, 2023 Results on Nov 09, 2023

Upcoming dividend of CA$0.04 per share at 7.8% yield

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Extendicare Inc. Announces Cash Dividend for the September 2023, Payable on October 16, 2023

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Upcoming dividend of CA$0.04 per share at 7.4% yield

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.039 in 2Q 2022)

Extendicare Inc. Declares Cash Dividend for the Month of August 2023, Payable on September 15, 2023

Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc.

Upcoming dividend of CA$0.04 per share at 6.5% yield

Extendicare's (TSE:EXE) Dividend Will Be CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of July 2023, Payable on August 15, 2023

Extendicare Inc. to Report Q2, 2023 Results on Aug 10, 2023

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of June 2023, Payable on July 17, 2023

Insufficient new directors

Independent Director recently bought CA$108k worth of stock

Upcoming dividend of CA$0.04 per share at 6.6% yield

Extendicare (TSE:EXE) Has Affirmed Its Dividend Of CA$0.04

Senior Vice President of ParaMed & CTO recently bought CA$206k worth of stock

Is Extendicare (TSE:EXE) Using Too Much Debt?

First quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.045 in 1Q 2022)

Upcoming dividend of CA$0.04 per share at 7.4% yield

CEO, President & Director recently bought CA$189k worth of stock

Upcoming dividend of CA$0.04 per share at 7.9% yield

CEO, President & Director exercised options to buy CA$258k worth of stock.

Full year 2022 earnings released: CA$0.051 loss per share (vs CA$0.10 profit in FY 2021)

Upcoming dividend of CA$0.04 per share at 7.1% yield

Extendicare Inc. Declares Dividend for the Month of February 2023, Payable on March 15, 2023

Upcoming dividend of CA$0.04 per share

Extendicare Inc. to Report Q4, 2022 Results on Mar 02, 2023

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of January 2023, Payable on February 15, 2023

Upcoming dividend of CA$0.04 per share

Extendicare Inc. Declares Cash Dividend for the Month of December 2022, Payable on January 16, 2023

Independent Director recently bought CA$151k worth of stock

Upcoming dividend of CA$0.04 per share

Third quarter 2022 earnings released: CA$0.049 loss per share (vs CA$0.031 profit in 3Q 2021)

Third quarter 2022 earnings released: CA$0.041 loss per share (vs CA$0.027 profit in 3Q 2021)